 Beneficiaries less than 35 years of age will be excluded because cancer incidence at these ages is low and therefore it is unlikely to be feasible from a costinformation perspective to include them. Beneficiaries 75 years of age or older will be excluded because it is unlikely they will have long-term follow-up. 